{"retracted":false,"update":{"timestamp":1380585600000,"doi":"10.1016/j.bbagen.2013.05.002","type":"err"},"doi":"10.1016/j.bbagen.2012.11.010","journal":"Biochimica et Biophysica Acta (BBA) - General Subjects","publisher":"Elsevier BV","title":"Erratum to “Sustained ERK inhibition by EGFR targeting therapies is a predictive factor for synergistic cytotoxicity with PDT as neoadjuvant therapy” [Biochim. Biophys. Acta 1830 (2013) 2659–2670]"}
